BLTE · Belite Bio, Inc
$157.01
+0.32 (+0.20%)
At close · Aug 27
Market Cap
$6.30B
Shares
40.27M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 6-K | 2026-08-13 | 2026-08-12 | |
| 6-K | 2026-08-11 | — | |
| 6-K | 2026-06-15 | 2026-06-12 | |
| 6-K | 2026-05-20 | — | |
| 6-K | 2026-04-21 | — | |
| 6-K | 2026-03-31 | — | |
| 20-F | 2026-03-31 | 2025-12-31 | |
| 6-K | 2026-03-02 | — | |
| 6-K | 2026-01-27 | — | |
| 6-K | 2025-12-02 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-12-01 | — | |
| 6-K | 2025-11-10 | — | |
| 6-K | 2025-09-08 | — | |
| 6-K | 2025-08-11 | — | |
| 6-K | 2025-08-07 | — | |
| 6-K | 2025-07-02 | — | |
| 6-K | 2025-05-21 | — | |
| 6-K | 2025-05-14 | 2025-05-13 | |
| 6-K | 2025-04-15 | — | |
| 6-K | 2025-03-28 | — | |
| 6-K | 2025-03-18 | — | |
| 6-K | 2025-03-17 | — | |
| 20-F | 2025-03-17 | 2024-12-31 | |
| 6-K | 2025-03-17 | — | |
| 6-K | 2025-02-27 | — | |
| 6-K | 2025-02-06 | — | |
| 6-K | 2024-11-12 | — | |
| 6-K | 2024-11-04 | — | |
| 6-K | 2024-09-03 | — | |
| 6-K | 2024-08-09 | — | |
| 6-K | 2024-05-14 | 2024-05-13 | |
| 6-K | 2024-04-26 | 2024-04-25 | |
| 6-K | 2024-03-22 | — | |
| 6-K | 2024-03-12 | 2024-03-11 | |
| 20-F | 2024-03-12 | 2023-12-31 | |
| 6-K | 2024-03-12 | 2024-03-11 | |
| 6-K | 2023-11-14 | 2023-11-13 | |
| 6-K | 2023-11-06 | — | |
| 6-K | 2023-08-09 | 2023-08-08 | |
| 6-K | 2023-07-24 | 2023-07-20 | |
| 6-K | 2023-06-16 | — | |
| 6-K | 2023-05-31 | 2023-05-30 | |
| 6-K | 2023-05-30 | — | |
| 6-K | 2023-05-11 | 2023-05-10 | |
| 6-K | 2023-04-25 | — | |
| 6-K | 2023-04-03 | 2023-03-31 | |
| 20-F | 2023-03-31 | 2022-12-31 | |
| 6-K | 2022-12-13 | — |
Showing 1–50 of 58 filings
Key facts
CIK
1889109
CUSIP
07782B104
13F (30d)
72 filings
72 filers
Visit website
Investor relations